Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Efficacy of GLP-1 on Intestinal Barrier Function in Patients With Short Bowel Syndrome and Intestinal Failure: A Preliminary Randomized Controlled Trial

NCT07297238 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT07297238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07297238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Efficacy of GLP-1 on Intestinal Barrier Function in Patients With Short Bowel Syndrome and Intestinal Failure: A Preliminary Randomized Controlled Trial
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Completed
Start date
January 24, 2026
Completion date
June 30, 2026
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal failure, short bowel syndrome (sbs)